Inhibition of Platelet Aggregation with a Glycoprotein IIb-IIIa Antagonist Does Not Prevent Thrombin Generation in Patients Undergoing Thrombolysis for Acute Myocardial Infarction Neal S. KleimanRussell P. TracyE. Magnus Ohman OriginalPaper Pages: 5 - 12
Homocysteine and Risk of Cardiovascular Disease Felicita AndreottiFrancesco BurzottaKillian Robinson OriginalPaper Pages: 13 - 21
Role of Extracellular Ionized Calcium in the In Vitro Assessment of GPIIb/IIIa Receptor Antagonists Sam S. RebelloJinbao HuangBenedict R. Lucchesi OriginalPaper Pages: 23 - 28
Ticlopidine Enhances the Platelet Inhibitory Capacity of Abciximab In Vitro Neal S. KleimanNikki GraziadeiMary Ann Mascelli OriginalPaper Pages: 29 - 36
Effect of Short-Term Aspirin Use on C-Reactive Protein DaLi FengRussell P. TracyGeoffrey H. Tofler OriginalPaper Pages: 37 - 41
Incidence of Factor V Leiden in Patients with Acute Myocardial Infarction Manohar S. GowdaMarjorie L. ZuckerBarbara D. Strope OriginalPaper Pages: 43 - 45
Prevention of Left Ventricular Remodeling by Percutaneous Transluminal Coronary Angioplasty Performed 24 Hours After the Onset of Acute Myocardial Infarction Ken KanamasaKinji IshikawaTakayuki Nakabayashi OriginalPaper Pages: 47 - 51
Soluble E-Selectin is Not a Marker of Unstable Coronary Plaque in Serum of Patients with Ischemic Heart Disease Marcello GalvaniDonatella FerriniFrancesca A. Nicolini OriginalPaper Pages: 53 - 60
Key References: Basic Fibrinolysis and Thrombolysis Selected References: 1987–1997 Felicita AndreottiEugenia De MarcoGiuseppe Patti OriginalPaper Pages: 61 - 68
References on a Wide Variety of Topics Pertaining to Coronary Artery Blood Flow and Patency Mukesh GoelSusan J. MarbleC. Michael Gibson OriginalPaper Pages: 85 - 93
Reference Guide to Cardiogenic Shock Complicating Acute Myocardial Infarction Venu MenonJudith S. Hochman OriginalPaper Pages: 95 - 98
Role of ACE Inhibition in Acute Coronary Syndromes Mushabbar SyedSteven Borzak OriginalPaper Pages: 107 - 109
Venous Thromboembolism in the Elderly: Introduction and Overview Henry I. Bussey OriginalPaper Pages: 111 - 112
Update in Unfractionated Heparin, Low-Molecular-Weight Heparins, and Heparinoids in the Elderly (Age ≤ 65 years) Sarah A. SpinlerChristy M. Evans OriginalPaper Pages: 117 - 117
Protein C, Protein S, and Antithrombin III Deficiencies Frederick A. Spencer OriginalPaper Pages: 127 - 127